Eradication of Helicobacter pylori Infection Using 7-day PCR-based Tailored Therapy
Background/Aims Standard triple therapy (STT; proton pump inhibitor [PPI]+clarithromycin+amoxicillin) used for Helicobacter pylori (H. pylori) eradication has shown low treatment success rates in recent years, which is most likely attributable to increased clarithromycin resistance. In this study, w...
Main Authors: | Youngwoo Kim, Heejun Kang, Sang-Gon Moon, Bohyoung Kim, Hyeyeon Lee, Chul-Hyun Lim, Jung-Hwan Oh |
---|---|
Format: | Article |
Language: | English |
Published: |
Yong Chan Lee
2023-06-01
|
Series: | The Korean Journal of Helicobacter and Upper Gastrointestinal Research |
Subjects: | |
Online Access: | http://www.helicojournal.org/upload/pdf/kjhugr-2023-0003.pdf |
Similar Items
-
A Pilot Study of Helicobacter pylori Eradication Using a Polymerase Chain Reaction-based Test for Clarithromycin Resistance
by: Yun Duk Jung, et al.
Published: (2017-12-01) -
Efficacy of 7-day Tailored Therapy for Helicobacter pylori Eradication based on Clarithromycin Resistance
by: June Hwa Bae, et al.
Published: (2023-07-01) -
An Economic Modeling Study of Helicobacter pylori Eradication: Comparison of Dual Priming Oligonucleotide-Based Multiplex Polymerase Chain Reaction and Empirical Treatment
by: Tae-Geun Gweon, et al.
Published: (2018-11-01) -
Ten-day tegoprazan-based concomitant therapy as a first-line treatment for Helicobacter pylori eradication
by: Yong Hwan Kwon, et al.
Published: (2023-07-01) -
Bismuth-Based Quadruple Therapy as First-Line Treatment for Clarithromycin-Resistant Helicobacter pylori Infection: A Prospective Randomized Comparison of 7- and 14-Day Treatment Regimens
by: Chul-Hyun Lim, et al.
Published: (2024-11-01)